Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury

Compounds targeting the sigma 2 receptor, which we recently cloned and showed to be identical with transmembrane protein 97 (σ2R/TMEM97), are broadly applicable therapeutic agents currently in clinical trials for imaging in breast cancer and for treatment of Alzheimer’s disease and schizophrenia. Th...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:ACS Chem Neurosci
Huvudupphovsmän: Vázquez-Rosa, Edwin, Watson, Michael R., Sahn, James J., Hodges, Timothy R., Schroeder, Rachel E., Cintrón-Pérez, Coral J., Shin, Min-Kyoo, Yin, Terry C., Emery, Josie L., Martin, Stephen F., Liebl, Daniel J., Pieper, Andrew A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6862717/
https://ncbi.nlm.nih.gov/pubmed/30421909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.8b00543
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk